The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Latest News

Gilead Discontinues Phase 3 ENHANCE-2 Trial | Image Credit: ©freshidea - stock.adobe.com
Gilead Discontinues Phase 3 ENHANCE-2 Trial of Magrolimab Plus Azacitidine in TP53-Mutant AML

September 27th 2023

The phase 3 ENHANCE-2 trial examining the frontline combination of magrolimab and azacitidine vs physician’s choice of venetoclax with azacitidine or intensive chemotherapy in patients with acute myeloid leukemia and TP53 mutations has been discontinued, according to an announcement from Gilead Sciences.

FDA
FDA Approves Bosutinib for Pediatric Ph+ CP-CML

September 27th 2023

Stephen M. Ansell, MD, PhD
Deeper Understanding of immune System Could Advance Treatment Options in Lymphoma

September 26th 2023

Amy W. Zhou, MD
Investigation of Novel Management Strategies Continues to Mitigate Disease-Related Toxicities Across Hematologic Malignancies

September 26th 2023

Paolo Strati, MD
Novel Combinations Seek to Build Off Lenalidomide/Rituximab Backbone in Indolent Lymphoma

September 25th 2023

Video Series
Video Interviews
Podcasts
Guillermo Garcia-Manero, MD; Amer Zeidan, MBBS, MHS
Monique Minnema, MD, PhD
Mikkael A. Sekeres, MD
Carmelo Carlo-Stella, MD, PhD
Matthew Lunning, DO, FACP
Nicholas James Short, MD
Tycel Phillips, MD
Michael Andreeff, MD, PhD
Mitchell E. Horwitz, MD
Ian Flinn, MD, PhD; Nicole Lamanna, MD; Jennifer R. Brown, MD, PhD; Constantine Tam, MD, MBBS
Latest CME Events & Activities

25th Annual International Lung Cancer Congress®

Register Now!

BURST CME™: Utilizing Pathology Reports to Inform Treatment Plans Across GI Cancers

View More

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

View More

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

View More

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

"D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective

View More

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

More News